Drug treatment for spinal muscular atrophy types II and III
about
Drug treatment for spinal muscular atrophy types II and IIIRasch analysis of clinical outcome measures in spinal muscular atrophy.Therapy development for spinal muscular atrophy in SMN independent targets.Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.
P2860
Drug treatment for spinal muscular atrophy types II and III
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Drug treatment for spinal muscular atrophy types II and III
@ast
Drug treatment for spinal muscular atrophy types II and III
@en
Drug treatment for spinal muscular atrophy types II and III
@en-gb
Drug treatment for spinal muscular atrophy types II and III
@nl
type
label
Drug treatment for spinal muscular atrophy types II and III
@ast
Drug treatment for spinal muscular atrophy types II and III
@en
Drug treatment for spinal muscular atrophy types II and III
@en-gb
Drug treatment for spinal muscular atrophy types II and III
@nl
prefLabel
Drug treatment for spinal muscular atrophy types II and III
@ast
Drug treatment for spinal muscular atrophy types II and III
@en
Drug treatment for spinal muscular atrophy types II and III
@en-gb
Drug treatment for spinal muscular atrophy types II and III
@nl
P2093
P2860
P1476
Drug treatment for spinal muscular atrophy types II and III
@en
P2093
Alexander FJE Vrancken
John HJ Wokke
Susan T Iannaccone
Wendy MJ Bosboom
P2860
P356
10.1002/14651858.CD006282.PUB2
P577
2009-01-21T00:00:00Z